本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rhythm Pharmaceuticals Inc.

89.82
-0.9600-1.06%
盘前:89.15-0.6700-0.75%08:04 EDT
成交量:54.38万
成交额:4,896.81万
市值:61.84亿
市盈率:-28.81
高:91.42
开:91.05
低:89.49
收:90.78
52周最高:122.20
52周最低:74.50
股本:6,885.21万
流通股本:6,539.41万
量比:0.51
换手率:0.83%
股息:- -
股息率:- -
每股收益(TTM):-3.1172
每股收益(LYR):-3.1100
净资产收益率:-117.04%
总资产收益率:-30.96%
市净率:60.05
市盈率(LYR):-28.88

数据加载中...

2025/01/10

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/05

重要事件披露

Form 8-K - Current report
2024/09/19

重要事件披露

Form 8-K - Current report
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/15

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities